capsules
Sponsors
Amsterdam UMC, Itb-Med AB, Amsterdam UMC Stichting, Institut De Recherches Internationales Servier IRIS, Stichting Amsterdam UMC
Conditions
(peri) MenopauseAcromegaly
pituitary tumorBenign Prostatic Hyperplasia
BPHBenign Prostatic Hyperplasia
Lower urinary tract symptomsClimacteric symptomsColorectal liver metastasesDiabetes MellitusDiabetes mellitus type 2
Phase 1
Bioequivalence of Diltiazem retard
Active, not recruitingRPCEC00000260
Start: 2018-10-01Target: 24Updated: 2026-03-30
Moringa in Diabetes
Active, not recruitingRPCEC00000395
Start: 2021-11-15Target: 66Updated: 2026-03-30
A Phase 1b/2, multicenter study of vorasidenib in combination with temozolomide (TMZ) in participants with IDH1- or IDH2-mutant glioma
Active, not recruitingCTIS2024-513738-39-00
Start: 2025-03-18Target: 17Updated: 2025-12-18
Phase 2
A 12-Month, Randomized, Controlled, Open-Label, Dose Escalation Study Evaluating Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of an Anti-CD2 Monoclonal Antibody, TCD601(siplizumab) Compared to Anti-Thymocyte Globulin (rATG), as Induction Therapy in de novo Renal Transplant Recipients
CompletedCTIS2023-507895-36-00
Start: 2021-06-06End: 2024-12-11Target: 33Updated: 2024-08-02
RENAISSANCE 2:
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of SPN-817 in Adults with Focal Onset Seizures
Not yet recruitingCTIS2025-520587-18-00
Target: 45Updated: 2025-11-24
Phase 3
D004 vs terazosin
Active, not recruitingRPCEC00000217
Start: 2017-01-15Target: 100Updated: 2026-03-30
Colilen IBS- Irritable Bowel Syndrome- adults-Phase III
Active, not recruitingRPCEC00000294
Start: 2018-12-10Target: 140Updated: 2026-03-30
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Octreotide Capsules in Patients Who Previously Tolerated and Demonstrated Biochemical Control on Injectable Somatostatin Receptor Ligands (SRL) Treatment
Active, not recruitingNL-OMON48842
Start: 2018-08-27Target: 5Updated: 2024-02-28
D004 (Palmex) vs Saw palmetto, Finasteride and Tamsulosin in patients with BPH
Active, not recruitingRPCEC00000373
Start: 2021-09-01Target: 200Updated: 2026-03-30
Precision psychiatry: Anti-inflammatory medication in Immuno-metabolic depression
Not yet recruitingCTIS2024-513907-15-01
Target: 140Updated: 2024-10-11
Protecting late-moderate preterm infants from respiratory tract infections and wheeze in their first year of life by using bacterial lysates
Not yet recruitingCTIS2024-518498-32-01
Target: 500Updated: 2024-12-05
COLLISION RELAPSE trial
Recurrent colorectal liver metastases: repeat local treatment +/- neoadjuvant systemic therapy, a phase III prospective randomized controlled trial
Not yet recruitingCTIS2024-515341-41-01
Target: 360Updated: 2024-12-11
Phase 4
Effect of antifungals on the intestinal microbiome – a randomized, controlled, proof-of-concept trial
RecruitingCTIS2023-503710-69-00
Start: 2026-01-05Target: 50Updated: 2025-07-23
The OPTIMIzE study;OPen label multicenter randomized Trial comparing standard
IMmunosuppression with tacrolimus and mycophenolate mofetil
with a low exposure tacrolimus regimen In combination with
everolimus in de novo renal transplantation in Elderly patients.
CompletedCTIS2024-516509-22-00
Start: 2019-07-22End: 2025-04-14Target: 381Updated: 2024-11-12
StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial
RecruitingCTIS2024-517343-31-00
Start: 2025-04-11Target: 600Updated: 2025-12-17
The role of online sleep intervention and hormone therapy on sleep, climacteric symptoms and mood in the perimenopause
RecruitingCTIS2024-512071-12-00
Start: 2025-10-29Target: 222Updated: 2025-10-22
The effect of transdermal 17-β-estradiol/progesterone supplementation on glucose regulation in peri- and postmenopausal women with type 1 and type 2 diabetes
Not yet recruitingCTIS2025-523214-83-00
Target: 48Updated: 2025-12-15